Infections with Mycobacterium tuberculosis are substantially increasing on a worldwide scale and new antibiotics are urgently needed to combat concomitantly emerging drug-resistant mycobacterial strains. The diarylquinoline TMC207 is a highly promising drug candidate for treatment of tuberculosis. This compound kills M. https://www.ngetikin.com/special-pick-MVP4-Moisture-Vapor-Protection-Anti-Fracture-and-Noise-Reduction-Membrane-special-save/